Polypeptide Says 32,350,302 Shares Tendered Into Offer
The shares tendered represented 97.98% of Polypeptide shares offered through the end of the additional acceptance period.
The shares tendered represented 97.98% of Polypeptide shares offered through the end of the additional acceptance period.